An immunological biomarker to predict MTX response in early RA-Reference-Cited by-同舟云学术

An immunological biomarker to predict MTX response in early RA

Published:2013-08-29 Issue:11 Volume:73 Page:2047-2053
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Ponchel Frederique,Goëb Vincent,Parmar Rekha,El-Sherbiny Yasser,Boissinot Marjorie,El Jawhari Jehan,Burska Agata,Vital Edward M,Harrison Stephanie,Conaghan Philip G,Hensor Elizabeth,Emery Paul

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference36 articles.

1. Rheumatoid arthritis. Pathophysiology and implications for therapy;Harris;N Engl J Med,1990

2. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis;Nell;Rheumatology,2004

3. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention;Quinn;Clin Exp Rheumatol,2003

4. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal—Results from a twelve-month randomized, double-blind, placebo-controlled trial;Quinn;Arthritis Rheum,2005

5. Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study;Emery;Ann Rheum Dis,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of T-Cell Receptor Repertoire for Differential Response to Methotrexate Treatment for Rheumatoid Arthritis;Immunological Investigations;2024-08-14

2. Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy;ACR Open Rheumatology;2024-02-27

3. Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals;Rheumatology;2023-09-07

4. Pathophysiology and stratification of treatment-resistant rheumatoid arthritis;Immunological Medicine;2023-07-18

5. Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance;Annals of the Rheumatic Diseases;2023-03-14